Publikationen in Zusammenarbeit mit Forschern von Hospital de Fuenlabrada (4)

2023

  1. Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study

    Multiple Sclerosis and Related Disorders, Vol. 69

2022

  1. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

2021

  1. Non-inflammatory causes of emergency consultation in patients with multiple sclerosis

    Neurologia, Vol. 36, Núm. 6, pp. 403-411

2017

  1. Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation

    Brain and Behavior, Vol. 7, Núm. 4